These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23808747)

  • 21. Prevalence of primary hyperaldosteronism in moderate to severe hypertension in the Central Europe region.
    Strauch B; Zelinka T; Hampf M; Bernhardt R; Widimsky J
    J Hum Hypertens; 2003 May; 17(5):349-52. PubMed ID: 12756408
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients.
    Rossi GP; Bernini G; Caliumi C; Desideri G; Fabris B; Ferri C; Ganzaroli C; Giacchetti G; Letizia C; Maccario M; Mallamaci F; Mannelli M; Mattarello MJ; Moretti A; Palumbo G; Parenti G; Porteri E; Semplicini A; Rizzoni D; Rossi E; Boscaro M; Pessina AC; Mantero F;
    J Am Coll Cardiol; 2006 Dec; 48(11):2293-300. PubMed ID: 17161262
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperaldosteronism as a common cause of resistant hypertension.
    Calhoun DA
    Annu Rev Med; 2013; 64():233-47. PubMed ID: 23092384
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A case of confirmed primary hyperaldosteronism diagnosed despite normal screening investigations.
    Carroll R; Gould A; Feltham J; Harper S
    N Z Med J; 2017 May; 130(1455):129-132. PubMed ID: 28494487
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Target organ damage in hyperaldosteronism versus essential hypertension--the Beer Sheba experience].
    Wolak T; Hazkani I; Friger M; Paran E
    Harefuah; 2010 Mar; 149(3):161-5, 194. PubMed ID: 20684167
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Primary aldosteronism].
    Fardella CE; Mosso LM; Carvajal CA
    Rev Med Chil; 2008 Jul; 136(7):905-14. PubMed ID: 18949169
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Primary hyperaldosteronism: a diagnostic algorithm].
    Del Giudice A; Prencipe M; Aucella F
    G Ital Nefrol; 2013; 30(3):. PubMed ID: 23832473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Epidemiological characteristics of subclinical target organ damage in urban adult residents with hypertension in Tianjin and its relationships with renin-angiotensin-aldosterone system].
    Li YL; Wan Z; Sun YM; Lu WL; Yao W; Yu XF; Wang Y; Wang JH
    Zhonghua Yi Xue Za Zhi; 2011 Feb; 91(6):415-9. PubMed ID: 21418917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Primary hyperaldosteronisms: from diagnosis to treatment].
    Wémeau JL; Mounier-Vehier C; Carnaille B; Douillard C
    Presse Med; 2009 Apr; 38(4):633-42. PubMed ID: 19299107
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Clear cell carcinoma of the kidney and Conn's syndrome in a patient with arterial hypertension--a case report].
    Swiatkowska-Stodulska R; Swierblewska E; Zielonko J; Sworczak K
    Wiad Lek; 2011; 64(2):104-8. PubMed ID: 22026274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary hyperaldosteronism without suppressed renin due to secondary hypertensive kidney damage.
    Oelkers W; Diederich S; Bähr V
    J Clin Endocrinol Metab; 2000 Sep; 85(9):3266-70. PubMed ID: 10999820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Atrial fibrillation in primary aldosteronism.
    Watson T; Karthikeyan VJ; Lip GY; Beevers DG
    J Renin Angiotensin Aldosterone Syst; 2009 Dec; 10(4):190-4. PubMed ID: 19617274
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The aldosterone/renin ratio as a screening test for primary aldosteronism.
    Rayner BL; Opie LH; Davidson JS
    S Afr Med J; 2000 Apr; 90(4):394-400. PubMed ID: 10957926
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Primary hyperaldosteronism with adrenal adenoma or hyperplasia: surgical case or not?].
    Muller ME; Doenz F; Matter M; Wuerzner G; Burnier M
    Rev Med Suisse; 2013 Sep; 9(397):1633-4, 1636-8. PubMed ID: 24073475
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus?
    Widimský J; Strauch B; Sindelka G; Skrha J
    Physiol Res; 2001; 50(6):603-7. PubMed ID: 11829322
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [What tests should be conducted for secondary arterial hypertension in hypertensive patients resistant to treatment?].
    Denolle T; Hanon O; Mounier-Vehier C; Marquand A; Fauvel JP; Laurent P; Tison E; Equine O; Ducloux D; Girerd X
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):1037-9. PubMed ID: 10989753
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endothelial progenitor cells in primary aldosteronism: a biomarker of severity for aldosterone vasculopathy and prognosis.
    Wu VC; Lo SC; Chen YL; Huang PH; Tsai CT; Liang CJ; Kuo CC; Kuo YS; Lee BC; Wu EL; Lin YH; Sun YY; Lin SL; Chen JW; Lin SJ; Wu KD;
    J Clin Endocrinol Metab; 2011 Oct; 96(10):3175-83. PubMed ID: 21816781
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Aldosterone excess and resistance to 24-h blood pressure control.
    Pimenta E; Gaddam KK; Pratt-Ubunama MN; Nishizaka MK; Cofield SS; Oparil S; Calhoun DA
    J Hypertens; 2007 Oct; 25(10):2131-7. PubMed ID: 17885558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The role of aldosteronism in causing obesity-related cardiovascular risk.
    Calhoun DA; Sharma K
    Cardiol Clin; 2010 Aug; 28(3):517-27. PubMed ID: 20621254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular outcomes in patients with primary aldosteronism after treatment.
    Catena C; Colussi G; Nadalini E; Chiuch A; Baroselli S; Lapenna R; Sechi LA
    Arch Intern Med; 2008 Jan; 168(1):80-5. PubMed ID: 18195199
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.